← Back to Search

Mindfulness-Based Therapy

Mindfulness-Based Cognitive Therapy for Post-Traumatic Stress Disorder

N/A
Waitlist Available
Led By Abigail Lott, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Positive PTSD screen (PC-PTSD ≥ 3)
Ability to provide informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 8, follow-up (1 month after the end of the intervention)
Awards & highlights

Study Summary

This trial will test the feasibility and acceptability of a mindfulness-based cognitive therapy (MBCT) intervention for primary care versus wait-list control in African Americans with chronic trauma exposure and comorbid PTSD and MDD.

Eligible Conditions
  • Post Traumatic Stress Disorder
  • Depression

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 8, follow-up (1 month after the end of the intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 8, follow-up (1 month after the end of the intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Difficulties in Emotion Regulation Scale (DERS) Score
Change in skin conductance
Client Satisfaction Questionnaire (CSQ) Score
+3 more
Secondary outcome measures
Change in Beck Depression Inventory-II (BDI-II) Score
Change in Clinician Administered PTSD Scale PTSD Determination
Change in Five Facet Mindfulness Questionnaire Score
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mindfulness-Based Cognitive TherapyExperimental Treatment1 Intervention
Participants randomized to this study arm will receive Mindfulness-Based Cognitive Therapy (MBCT) for 8 weeks.
Group II: Wait-list Control GroupActive Control1 Intervention
Participants randomized to the wait-list control study arm will be administered the study assessments while not receiving active treatment. Participants will be given the opportunity to participate in the MBCT intervention following completion of the study assessments.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness-Based Cognitive Therapy
2013
Completed Phase 2
~5470

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,627 Previous Clinical Trials
2,560,685 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
827 Previous Clinical Trials
668,664 Total Patients Enrolled
Abigail Lott, PhDPrincipal Investigator - Emory University
Emory University
1 Previous Clinical Trials
30 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there availability for enrolment in this clinical investigation?

"The study is currently recruiting, as detailed on clinicaltrials.gov; the trial was initially posted on September 14th 2018 and most recently revised on September 27th 2022."

Answered by AI

What is the intended outcome of this medical experiment?

"This clinical study aims to gauge the efficacy of this intervention through a quantitative assessment of Changes in Difficulties in Emotion Regulation Scale (DERS) Score, over an 8-week period. Secondary outcomes include modifications to PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 (PCL-5) Score, with total scores ranging from 0 - 80; Primary Care PTSD Screen (PC-PTSD), which requires respondents answer yes or no to 4 questions that can diagnose someone as having PTSD if 3 out of 4 are answered positively; and Five Facet Mindfulness Questionnaire Score where higher scores indicate"

Answered by AI

How many participants are being monitored in this clinical investigation?

"Affirmative. According to the information published on clinicaltrials.gov, this medical study remains open for participants and was initially posted in September 2018. As of now, it seeks 80 patients from a single trial site."

Answered by AI

Is this research initiative open to individuals below retirement age?

"The inclusion criteria for this study specifies that participants must be between 18 and 65 years old. There are 367 studies available to those younger than 18, while 1354 clinical trials exist in total for patients who are over the age of 65."

Answered by AI

Who possesses the necessary requirements to be accepted into this medical study?

"This research project is open to 80 individuals who experienced moral injury and are between 18-65 years of age. Crucially, these participants must demonstrate a willingness to partake in the study as well as have had at least three traumatic experiences during their childhood or adulthood (criterion A traumas)."

Answered by AI

Who else is applying?

What state do they live in?
Georgia
How old are they?
18 - 65
What site did they apply to?
Grady Health System
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
~12 spots leftby Mar 2025